Effects of monthly dose and regular dosing of intravenous active vitamin d use on mortality among patients undergoing hemodialysis

Pharmacotherapy

Volumn 29, Issue 2, 2009, Pages 154-164

  St Peter, Wendy L ^a,b   Li, Shuling ^a   Liu, Jiannong ^a   Gilbertson, David T ^a   Arneson, Thomas J ^a   Collins, Allan J ^a,c  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Hemodialysis; Mortality; Vitamin d

Indexed keywords

CALCITRIOL; DOXERCALCIFEROL; HEMOGLOBIN; PARICALCITOL; RECOMBINANT ERYTHROPOIETIN; UREA; VITAMIN D;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; UNITED STATES; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 59949098577     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.2.154     Document Type: Article

References (25)

1. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69: 842-56.
2. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338: 777-83.
3. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81: 353-73.
4. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third national health and nutrition examination survey, 1988-1994. Am J Clin Nutr 2002;76: 187-92.
5. van der Wielen RP, Lowik MR, van den BH, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346: 207-10.
6. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85: 860-8.
7. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167: 1730-7.
8. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72: 1004-13.
9. Coen G, Mantella D, Manni M, et al. 25-Hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 2005;68: 1840-8.
10. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71: 31-8.
11. Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int 2005; 68: 1973-81.
12. Seibert E, Levin NW, Kuhlmann MK. Immunomodulating effects of vitamin D analogs in hemodialysis patients. Hemodial Int 2005;9(suppl 1): S25-9.
13. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176: 208-13.
14. Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16: 1115-25.
15. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70: 771-80.
16. Tentori F, Hunt WC, Stidley CA, et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006;70: 1858-65.
17. Foley RN, Li S, Liu J, Gilbertson DT, Chen SC, Collins AJ. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2004;16: 210-18.
18. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999;14: 270-7.
19. U.S. Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006.
20. U.S. Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
21. . Young EW, Albert JM, Akiba T, et al. Vitamin D therapy and mortality in the dialysis outcomes and practice patterns study (DOPPS) [abstract]. J Am Soc Nephrol 2005;16: 278A.
22. Young EW, Albert JM, Akiba T, et al. Vitamin D therapy and mortality in the dialysis outcomes and practice patterns study (DOPPS). Poster presentation at the 38th annual scientific meeting of the American Society of Nephrology, Philadelphia, PA, November 8-13, 2005.
23. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006;69: 33-43.
24. Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007;147: 840-53.
25. Dobrez DG, Mathes A, Amdahl M, Marx SE, Melnick JZ, Sprague SM. Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. Nephrol Dial Transplant 2004;19: 1174-81.